Medadent Biomedical INC (DOT 2622137) is a California-based intrastate carrier headquartered in Torrance, CA. As of June 2, 2026 at 12:37 PM, operating authority is active but without for-hire authority. TruckGraph has detected 1 risk signal on this carrier, including: no active insurance filing on record. TruckGraph rates this carrier "Do Not Tender" based on FMCSA compliance data, inspection history, insurance status, and network connection analysis. Last synced: June 2, 2026 at 12:37 PM.
Source: FMCSA compliance records, inspection data, crash records, insurance filings, and TruckGraph analysis. View methodology
Data sourced from FMCSA public records and TruckGraph independent analysis. This is not legal advice, not a guarantee of carrier safety, and not a compliance certification. Verify through official FMCSA sources before tendering. Last synced: .
No reviews yet — be the first to share your experience with this carrier.
Is Steve Kuznetsov authorized to operate?
Steve Kuznetsov's USDOT number is active but it does not hold operating authority for for-hire interstate operations. It may operate as a private carrier. Verify status before tendering.
What is Steve Kuznetsov's safety record?
Steve Kuznetsov does not have a substantial inspection history on record. This may indicate limited interstate operations.
How many trucks does Steve Kuznetsov operate?
Steve Kuznetsov operates 1 power units with approximately 1 drivers.
Is Steve Kuznetsov insured?
Insurance filing details are not available in the current dataset. Verify directly with the carrier before tendering.
Has Steve Kuznetsov had any risk indicators?
Steve Kuznetsov has a risk score of 0/100 (Monitor) with 1 active risk signal. Review the risk section above and verify independently before tendering.
What is the DOT number for Steve Kuznetsov?
Steve Kuznetsov's DOT number is 2622137. These identifiers are assigned by the FMCSA and can be used to look up this carrier in official compliance databases.
For journalists and researchers
Truck Graph data is open and citable. For press inquiries, contact our editorial team.
